DE2409862C3 - Verwendung einer oral applizierbaren Immunoglobulinkombination - Google Patents

Verwendung einer oral applizierbaren Immunoglobulinkombination

Info

Publication number
DE2409862C3
DE2409862C3 DE19742409862 DE2409862A DE2409862C3 DE 2409862 C3 DE2409862 C3 DE 2409862C3 DE 19742409862 DE19742409862 DE 19742409862 DE 2409862 A DE2409862 A DE 2409862A DE 2409862 C3 DE2409862 C3 DE 2409862C3
Authority
DE
Germany
Prior art keywords
immunoglobulin
combination
immunoglobulins
orally administered
pathog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19742409862
Other languages
German (de)
English (en)
Other versions
DE2409862B2 (de
DE2409862A1 (de
Inventor
Ed. Dr. Crissier Leresche (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biokema Sa Crissier (schweiz)
Original Assignee
Biokema Sa Crissier (schweiz)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biokema Sa Crissier (schweiz) filed Critical Biokema Sa Crissier (schweiz)
Publication of DE2409862A1 publication Critical patent/DE2409862A1/de
Publication of DE2409862B2 publication Critical patent/DE2409862B2/de
Application granted granted Critical
Publication of DE2409862C3 publication Critical patent/DE2409862C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19742409862 1973-11-28 1974-03-01 Verwendung einer oral applizierbaren Immunoglobulinkombination Expired DE2409862C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1669273A CH590064A5 (no) 1973-11-28 1973-11-28

Publications (3)

Publication Number Publication Date
DE2409862A1 DE2409862A1 (de) 1975-06-12
DE2409862B2 DE2409862B2 (de) 1980-04-30
DE2409862C3 true DE2409862C3 (de) 1981-01-08

Family

ID=4419439

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742409862 Expired DE2409862C3 (de) 1973-11-28 1974-03-01 Verwendung einer oral applizierbaren Immunoglobulinkombination

Country Status (4)

Country Link
CH (1) CH590064A5 (no)
DE (1) DE2409862C3 (no)
FR (1) FR2253533B1 (no)
GB (1) GB1442283A (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3272680D1 (en) * 1981-05-01 1986-09-25 Miles Lab Oral pharmaceutical composition containing immune globulin
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5932250A (en) * 1982-06-03 1999-08-03 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5215746A (en) * 1982-06-03 1993-06-01 Stolle Research And Development Corporation Anti-cholesterolemic egg, vaccine and method for production, and use
US4879110A (en) * 1983-10-27 1989-11-07 Stolle Research And Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5849349A (en) * 1982-06-03 1998-12-15 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5242691A (en) * 1982-06-03 1993-09-07 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5130128A (en) * 1982-06-03 1992-07-14 Stolle Research & Development Corporation Use of honey as vaccine
US5753268A (en) * 1982-06-03 1998-05-19 Dcv Biologics, L.P. Anti-cholesterolemic egg, vaccine and method for production, and use
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use

Also Published As

Publication number Publication date
CH590064A5 (no) 1977-07-29
DE2409862B2 (de) 1980-04-30
GB1442283A (en) 1976-07-14
FR2253533A1 (no) 1975-07-04
FR2253533B1 (no) 1978-06-30
DE2409862A1 (de) 1975-06-12

Similar Documents

Publication Publication Date Title
DE2409862C3 (de) Verwendung einer oral applizierbaren Immunoglobulinkombination
DE3689717T2 (de) Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
DE1810438A1 (de) Prophylaktisches oder therapeutisches Praeparat
DE69730152T2 (de) Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate
DE3504221A1 (de) Verfahren zur passiven immunisierung von saeugern unter verwendung von antikoerpern von gefluegel und/oder boviden und antikoerpergemische
DE69432929T2 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
EP2497480A1 (de) Extrakte aus phototrophen Mikroorganismen als Adjuvans
DE3882781T2 (de) Impfstoff gegen Pasteurella.
Van Heerden A retrospective study on 120 natural cases of canine ehrlichiosis
DE2746974A1 (de) Verwendung der pseudomonsaeure und ihrer salze und ester
DE2538994A1 (de) Bakterieller impfstoff und verfahren zu seiner herstellung
DE2816942C2 (de) Impfstoff gegen Rhinitis atrophicans beim Schwein
DE1792256C3 (de) Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
DE2620287C2 (de) Verwendung eines parenteralen Impfstoffes bei Schweinen, Kühen und Schafen
DE2057544C3 (de) Impfstoff gegen ein neonatales Kälberdiarrhoevirus, Verfahren zu seiner Herstellung und seine Verwendung
DE2520310A1 (de) Verfahren zur herstellung von immunisierender milch und/oder kolostrum
DE2360118B2 (de) Impfstoff gegen Ferkel-Colibacillose
DE2602478C3 (de) Impfstoff gegen die Panleukopenie der Feliden
DE2728806A1 (de) Auf oralem wege einzunehmender antiparasitaerer impfstoff, verfahren zu dessen herstellung und anwendungsmethode des impfstoffs bei saeugetieren
DE69208854T2 (de) Impfstoff-Zubereitung zur Vorbeugung gegen bei Tieren durch Chlamydia psitacci verursachte Fehlgeburt
AT300193B (de) Verfahren zur Herstellung von Mastitis-Immunoglobulin
DE2126957A1 (de) Impfstoff gegen Gänsehepatitis
DE2001671C3 (de) Plyvalentes Mastits-Immunglobulin und dessen Verwendung bei der Bekämpfung der Mastits
DE2034118A1 (en) Xenogenic nucleic acids for enhancing antigenicity - of peptides and proteins
DE1617538C3 (de) Verfahren zur Herstellung von Tetanus-Antitoxin

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee